Distribution of serum zinc levels in hemodialysis patients–factors related to hypozincemia–
Nobuo Nagano(Kirin (Japan)), Takaaki Tsutsui(Hidaka Hospital), Masami Minami(Towa Pharmaceutical (Japan)), Kosaku Nitta(Tokyo Women's Medical University), Kyoko Ito, Tetsuya Ogawa(Nihon University), Chie Tsunoda(Hidaka Hospital), Tetsuo Ando, Yukihiro Otaka(Hidaka Hospital), Satoru Sunaga(Hidaka Hospital), Haruno Nakajima(Hidaka Hospital), Noriko Tamei(Hidaka Hospital), Atsushi Nohara(Kanazawa University), Ayako Hoshi(Hidaka Hospital), Hideki Hayashi(University of Nagasaki), Yuko Oishi(Gunma University), Tomoi Nohara(Hidaka Hospital)
Cited by 4
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170